The largest database of trusted experimental protocols

53 protocols using b6129sf2 j

1

Transgenic Mouse Models for Alzheimer's Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were conducted in accordance with the University of Virginia Institutional Animal Care and Use Committee. Animals were housed in a temperature and humidity controlled vivarium (22–24°C, ~40% humidity) and were provided with food and water ad libitum. 3xTg experiments were conducted with 8–13 month old female 3xTg mice on a B6129 background (Oddo et al., 2003 (link)) (Jackson Laboratory #034830), with age-matched B6129SF2/J (Jackson Laboratory #101045) females as wild type controls. 5xFAD experiments were conducted with 7 month old female heterozygous 5xFAD mice on a C57BL/6J background (Oakley et al., 2006 (link)) (Jackson Laboratory #034848), with littermates genotyped as not expressing the mutant transgene serving as wild type controls. PS19 experiments were conducted with 7 month old female heterozygous PS19 mice on a B6C3 background (Yoshiyama et al., 2007 (link)) (Jackson Laboratory #008169), with littermates genotyped as not expressing the mutant transgene serving as wild type controls. For microglia depletion experiments, mice were given chow formulated with PLX3397 (660mg/kg) or control chow for 7 days before light cycle shift and were maintained on PLX or control chow for the remainder of the experiment.
+ Open protocol
+ Expand
2

Xenograft Tumor Model for PET Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female athymic nude mice (10–12 weeks old) were received from Charles River Laboratories (Saint-Constant, QC, Canada) and injected subcutaneously with 3 × 106 KM12 cells in 100 µL PBS/Matrigel (50:50) into the upper left flank. After about 3 to 4 weeks, subcutaneous KM12 tumors reached sizes of ~ 400–500 mm3 suitable for PET imaging experiments. Female B6129SF2/J (wild-type control) and female B6129S2-Ntrk2tm1Bbd/J (TrkB 50% knockout) mice were obtained from Jackson Laboratories (JAX™ Bar Harbor, ME, USA) at the age of 10–12 weeks and used over the next 3–5 months.
+ Open protocol
+ Expand
3

Murine SLE1B Congenic Model Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
B6/129SF2/J (stock number 101045) and C57BL/6 (stock number 000664) mice were originally purchased from The Jackson Laboratory (Bar Harbor, ME) and bred in house. B6 mice congenic for the Sle1b sub-locus (B6.Sle1b) were generated as described previously [46 (link)–48 (link)] and bred in house. All the mice used in this study were females of 2–3 months (mo) of age and were housed in a specific pathogen free facility. All procedures were performed in accordance with Pennsylvania State University Institutional Animal Care and Use Committee (IACUC) guidelines.
+ Open protocol
+ Expand
4

Transgenic Mouse Models for Alzheimer's Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were conducted in accordance with the University of Virginia Institutional Animal Care and Use Committee. Animals were housed in a temperature and humidity controlled vivarium (22–24°C, ∼40% humidity) and were provided with food and water ad libitum. 3xTg experiments were conducted with 8–13 mo female 3xTg mice on a B6129 background (Oddo et al., 2003 (link)) (Jackson Laboratory #034830), with age-matched B6129SF2/J (Jackson Laboratory #101045) females as wild type controls. 5xFAD experiments were conducted with 7 mo female heterozygous 5xFAD mice on a C57BL/6J background (Oakley et al., 2006 (link)) (Jackson Laboratory #034848), with littermates genotyped as not expressing the mutant transgene serving as wild type controls. PS19 experiments were conducted with 7 mo female heterozygous PS19 mice on a B6C3 background (Yoshiyama et al., 2007 (link)) (Jackson Laboratory #008169), with littermates genotyped as not expressing the mutant transgene serving as wild type controls. For microglia depletion experiments, mice were given chow formulated with PLX3397 (660 mg/kg) or control chow for 7 days before light cycle shift and were maintained on PLX or control chow for the remainder of the experiment.
+ Open protocol
+ Expand
5

Alzheimer's Mouse Model Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
5xFAD wild-type (B6SJLF1/J; male n = 20, female n = 33) and transgenic (B6SJLTg(APPSwF1Lon,PSEN1*M146L*L286V)6799Vas/Mmjax; male n = 23, female n = 33) mice and 3xTG wild-type (B6129SF2/J; male n = 24, female n = 35) and transgenic (B6;129Psen1tm1Mpm Tg(APPSwe, tauP301L)1Lfa/Mmjax; male n = 21, female n = 35) mice were obtained from Jackson Laboratory (Bar Harbor, USA). Because we were primarily comparing WT and TG mice, there was no random assignment to groups. A minimum of 7 mice per group were used for behavioural experiments; our previous work indicates power of 0.80 can be achieved with a sample size of 6 mice (α = 0.05). Differences in sample sizes between sexes was a result of attrition46 (link). Mice were housed in polyethylene cages (16 × 12 × 26 cm) with corncob bedding, crink-l’Nest and cotton nest squares and food (Tekland Global 16% Protein Rodent Maintenance Diet, Harlan Tekland, USA) and water available ad libitum. Mice were tested during the light phase of a 12 h light/dark cycle (0800 lights on; 2000h lights off). All procedures followed the guidelines of the Canadian Council on Animal Care and were approved by the Animal Care Committee at the University of Guelph and the University of Western Ontario (2006-103 and 2006-104). Object recognition testing started when mice were 12 months of age after they were tested in different touchscreen tasks.
+ Open protocol
+ Expand
6

Malaria Susceptibility in Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice deficient in phagocyte NOX2 (NADPH oxidase, gp91phox–/–; strain B6.129S-Cybbtm1Din/J; #002365) and age- and gender-matched control C57BL/6J (# 000664), or deficient in mitochondria superoxide dismutase 1 (SOD1) (strain B6;129S-Sod1tm1Leb/J, #002972) and age- and gender-matched B6129SF2/J control (#101045) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). KO or control mice (n = 8/group) were infected by 106P. berghei and evaluated for clinical scores and survival as described above. On day 6 p.i., an aliquot of blood was obtained to estimate parasitemia as above.
+ Open protocol
+ Expand
7

Alzheimer's Mouse Model Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male 3xTg-AD [B6129-Psen1tm1MpmTg (APPSwe, tauP30L) 1Lfa/J] [35 (link)] and wild-type mice (B6129SF2/J) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). The 3xTg-AD, overexpressing mutant amyloid precursor protein (APP (APPSwe)), presenilin 1 (PSEN1 (PS1M146V)), and hyperphosphorylated tau (tauP301L), were originally generated by co-injecting two independent transgene constructs encoding human APPSwe and tauP301L (4R/0 N) (controlled by murine Thy1.2 regulatory elements) into single-cell embryos harvested from mutant homozygous PS1M146V knock-in mice. Wild-type mice of mixed genetic background 129/C57BL6 were used as controls. These mice have been characterized and described by Oddo et al. [35 (link)]. The animals were maintained on a 12-h light/dark cycle in a temperature- and humidity-controlled rooms and food and water were available ad libitum.
+ Open protocol
+ Expand
8

Pathogenic Mouse Models for Immunological Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pathogen-free, male C57BL/6 mice, 6 to 8 weeks old, weighing 19 to 21 g were purchased from Orient Bio (Sungnam, Korea). B6.129-Mertktm1Gr1/J (MerTK−/−) and wild-type (WT) control mice with an identical background (B6.129SF2/J) were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA). STAT1−/− mice were from the Charles River Laboratory. STAT1−/− mice were on a C57BL/6 background (Orient Bio). MerTK−/−, STAT1−/−, and the respective WT mice were age-matched (7 to 10 weeks old) and sex-matched for all experiments. The Animal Care Committee of the Ewha Medical Research Institute approved the experimental protocol. Mice were cared for and handled in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
+ Open protocol
+ Expand
9

Knockout Mouse Model for DUSP4 Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The animal protocol (2012A0000089) used in this study was approved by The Ohio State University Institutional Animal Care and Use Committee and conformed to the Guide for the Care and Use of Laboratory Animals published by National Institute of Health (NIH Publication NO. 85-23, revised 1996). Male mice (10 weeks), of body weight > 20 g, were utilized in this study. Mice with a targeted DUSP4 gene knockout (B6;129-Dusp4tm1Jmol/J) and wild-type (WT) mice (B6129SF2/J) were purchased from Jackson Laboratory.
+ Open protocol
+ Expand
10

Transgenic Mouse Model of Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male 3xTg-AD mice [B6129-Psen1tm1MpmTg (APPSwe, tauP30L) 1Lfa/J] [25 (link)] and wild-type mice (B6129SF2/J) were purchased from Jackson Laboratories. The 3xTg-AD, overexpressing mutant APP (APPSwe), PSEN1 (PS1M146V), and hyperphosphorylated tau (tauP301L), were originally generated by co-injecting two independent transgene constructs encoding human APPSwe and tauP301L (4R/0 N) (controlled by murine Thy1.2 regulatory elements) in single-cell embryos harvested from mutant homozygous PS1M146V knock-in mice. Wild-type mice of mixed genetic background 129/C57BL6 were used as controls. These mice have been characterized and described by Oddo et al. [25 (link)]. The animals were maintained on a 12-h light/dark cycle in temperature- and humidity-controlled rooms, and food and water were available ad libitum. All experiments were carried out according to the Directive 2010/63/EU and the Italian law (D.Lgs. 26/2014), and were approved by the Italian Ministry of Health.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!